These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure. Gao J, Zucker IH, Gao L. Am J Hypertens; 2014 Oct; 27(10):1248-56. PubMed ID: 24687998 [Abstract] [Full Text] [Related]
24. Central Ang II (Angiotensin II)-Mediated Sympathoexcitation: Role for HIF-1α (Hypoxia-Inducible Factor-1α) Facilitated Glutamatergic Tone in the Paraventricular Nucleus of the Hypothalamus. Sharma NM, Haibara AS, Katsurada K, Nandi SS, Liu X, Zheng H, Patel KP. Hypertension; 2021 Jan; 77(1):147-157. PubMed ID: 33296248 [Abstract] [Full Text] [Related]
27. Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction. Huang BS, Ahmad M, White RA, Marc Y, Llorens-Cortes C, Leenen FH. Cardiovasc Res; 2013 Mar 01; 97(3):424-31. PubMed ID: 23257024 [Abstract] [Full Text] [Related]
28. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism. Ammarguellat F, Larouche I, Schiffrin EL. Circulation; 2001 Jan 16; 103(2):319-24. PubMed ID: 11208696 [Abstract] [Full Text] [Related]
32. Central mechanisms of acute ANG II modulation of arterial baroreflex control of renal sympathetic nerve activity. Sanderford MG, Bishop VS. Am J Physiol Heart Circ Physiol; 2002 May 16; 282(5):H1592-602. PubMed ID: 11959620 [Abstract] [Full Text] [Related]
33. Effect of intracerebroventricular benzamil on cardiovascular and central autonomic responses to DOCA-salt treatment. Abrams JM, Engeland WC, Osborn JW. Am J Physiol Regul Integr Comp Physiol; 2010 Dec 16; 299(6):R1500-10. PubMed ID: 20926762 [Abstract] [Full Text] [Related]
35. Baroreflex control of heart rate and cardiac hypertrophy in angiotensin II-induced hypertension in rabbits. Malpas SC, Groom AS, Head GA. Hypertension; 1997 Jun 16; 29(6):1284-90. PubMed ID: 9180630 [Abstract] [Full Text] [Related]
36. Central and peripheral slow-pressor mechanisms contributing to Angiotensin II-salt hypertension in rats. Lu J, Wang HW, Ahmad M, Keshtkar-Jahromi M, Blaustein MP, Hamlyn JM, Leenen FHH. Cardiovasc Res; 2018 Feb 01; 114(2):233-246. PubMed ID: 29126194 [Abstract] [Full Text] [Related]
37. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension. Rahmouni K, Sibug RM, De Kloet ER, Barthelmebs M, Grima M, Imbs JL, De Jong W. Eur J Pharmacol; 2002 Feb 02; 436(3):207-16. PubMed ID: 11858800 [Abstract] [Full Text] [Related]
38. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats. Park CG, Leenen FH. J Korean Med Sci; 2001 Oct 02; 16(5):553-7. PubMed ID: 11641522 [Abstract] [Full Text] [Related]